Literature DB >> 28802940

Fatigue in Parkinson's Disease.

Benzi M Kluger1.   

Abstract

Fatigue is a common symptom in Parkinson's disease (PD), affecting approximately half of all patients. Fatigue is a significant contributor to reduction in quality of life and is a leading cause of disability. Despite the clear impact of fatigue on persons living with PD, research progress has been slow in this area in terms of uncovering the mechanisms of fatigue and there are currently no evidence-based treatments. Although fatigue is often viewed as a subjective and nonspecific symptom which cannot be studied rigorously, there is an emerging science of fatigue which is based on a careful and precise taxonomy of the construct of fatigue. In this chapter we will review advances in our conceptualization of fatigue, including providing definitions useful for both research and clinical care. We will then provide an overview for an approach to the assessment and management of persons with PD who complain of problematic fatigue. We will conclude by reviewing methods for clinical research, including outcome measures for clinical trials, findings from recent mechanistic studies, and suggestions for future research.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case definition; Clinical research; Fatigue; Management; Parkinson's

Mesh:

Year:  2017        PMID: 28802940     DOI: 10.1016/bs.irn.2017.05.007

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  6 in total

1.  Prevalence and Cumulative Incidence of Caregiver-Reported Aggression in Advanced Parkinson Disease and Related Disorders.

Authors:  Zachary A Macchi; Janis Miyasaki; Maya Katz; Nicholas Galifianakis; Stefan Sillau; Benzi M Kluger
Journal:  Neurol Clin Pract       Date:  2021-12

2.  Association between fatigue and motor progression in Parkinson's disease in southern Chinese.

Authors:  Hong-Xiang Yu; Meng-Ruo Guo; Gang Li; Bei Zhang
Journal:  Neurol Sci       Date:  2019-09-04       Impact factor: 3.307

3.  Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease.

Authors:  Marina Picillo; Onanong Phokaewvarangkul; Yu-Yan Poon; Cameron C McIntyre; Sinem Balta Beylergil; Renato P Munhoz; Suneil K Kalia; Mojgan Hodaie; Andres M Lozano; Alfonso Fasano
Journal:  Mov Disord       Date:  2020-11-09       Impact factor: 10.338

4.  The Neurobiology of Pathological Fatigue: New Models, New Questions.

Authors:  Annapoorna Kuppuswamy
Journal:  Neuroscientist       Date:  2021-01-15       Impact factor: 7.235

5.  Relationship between Fatigue and Self-Perception of Constipation in Community-Dwelling Older Adults during the COVID-19 Pandemic.

Authors:  Chisato Hayashi
Journal:  Int J Environ Res Public Health       Date:  2022-07-09       Impact factor: 4.614

6.  Validation of new diagnostic criteria for fatigue in patients with Parkinson disease.

Authors:  Mattia Siciliano; Benzi Kluger; Rosa De Micco; Carlo Chiorri; Valeria Sant'Elia; Marcello Silvestro; Alfonso Giordano; Gioacchino Tedeschi; Luca Passamonti; Luigi Trojano; Alessandro Tessitore
Journal:  Eur J Neurol       Date:  2022-06-06       Impact factor: 6.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.